1
项与 Anti-CD19 CAR T-cells(KK Women's and Children's Hospital) 相关的临床试验CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol
The purpose of this study is to describe feasibility of delivering point-of-care manufactured CD19-directed CAR T-cell therapy to patients with relapsed/ refractory B-lineage leukaemia/ lymphoma.
100 项与 Anti-CD19 CAR T-cells(KK Women's and Children's Hospital) 相关的临床结果
100 项与 Anti-CD19 CAR T-cells(KK Women's and Children's Hospital) 相关的转化医学
100 项与 Anti-CD19 CAR T-cells(KK Women's and Children's Hospital) 相关的专利(医药)
100 项与 Anti-CD19 CAR T-cells(KK Women's and Children's Hospital) 相关的药物交易